🇮🇳IN
Sign In
MO

MOLBIO

NSE

Molbio Diagnostics Ltd

₹1,486.40

-16.60(-1.10%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

MOLBIO valuation summary

Molbio Diagnostics Ltd trades at 65.8 times trailing earnings. Return on equity is 13.8% and return on capital employed is 18.0%. That P/E equals an earnings yield of 1.5%. The median P/E across 5 listed Medical Devices companies is 60.6, so Molbio Diagnostics Ltd trades at a 82% premium to that median.

P/E65.8
ROE13.8%
ROCE18.0%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer